Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamil Musilek

Showing results (71-80 of 199) with videos related to

Pageof 20
Sort By:
Toxicology Mechanisms and Methods|September 5, 2009
A comparison of the neuroprotective efficacy of newly developed oximes (K117, K127) and currently available oxime (obidoxime) in tabun-poisoned ratsJiri Kassa, Jana Zdarova Karasova, Kamil Musilek, et al.
International Journal of Molecular Sciences|September 11, 2009
Effect of seven newly synthesized and currently available oxime cholinesterase reactivators on cyclosarin-intoxicated ratsJana Zdarova Karasova, Jiri Kassa, Kamil Musilek, et al.
Talanta|May 24, 2024
Towards cost-effective drug discovery: Reusable immobilized enzymes for neurological disease researchRudolf Andrys, Charline Monnier, Evica Antonijević Miljaković, et al.
Journal of Medicinal Chemistry|October 11, 2007
Design of a potent reactivator of tabun-inhibited acetylcholinesterase--synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203)Kamil Musilek, Daniel Jun, Jiri Cabal, et al.
Basic & Clinical Pharmacology & Toxicology|April 18, 2014
In vivo evaluation of cholinesterase activity, oxidative stress markers, cyto- and genotoxicity of K048 oxime–a promising antidote against organophosphate poisoningSuzana Zunec, Nevenka Kopjar, Davor Zeljezić, et al.
Molecules (Basel, Switzerland)|October 26, 2007
Targeted synthesis of 1-(4-hydroxyiminomethylpyridinium)-3-pyridiniumpropane dibromide--a new nerve agent reactivatorKamil Kuca, Kamil Musilek, Martin Paar, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 18, 2010
A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and miceJiri Kassa, Jana Zdarova Karasova, Filip Caisberger, et al.
ACS Omega|March 18, 2024
C-3 Steroidal Hemiesters as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 10Michaela Hanzlova, Barbora Slavikova, Marina Morozovova, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 24, 2010
Changes of rat plasma total low molecular weight antioxidant level after tabun exposure and consequent treatment by acetylcholinesterase reactivatorsMiroslav Pohanka, Jana Zdarova Karasova, Kamil Musilek, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 12, 2012
Structure-activity relationship for the reactivators of acetylcholinesterase inhibited by nerve agent VXKamil Kuca, Kamil Musilek, Daniel Jun, et al.
Pageof 20

Showing results (71-80 of 199) with videos related to

Sort By:
Pageof 20
Toxicology Mechanisms and Methods|September 5, 2009
A comparison of the neuroprotective efficacy of newly developed oximes (K117, K127) and currently available oxime (obidoxime) in tabun-poisoned ratsJiri Kassa, Jana Zdarova Karasova, Kamil Musilek, et al.
International Journal of Molecular Sciences|September 11, 2009
Effect of seven newly synthesized and currently available oxime cholinesterase reactivators on cyclosarin-intoxicated ratsJana Zdarova Karasova, Jiri Kassa, Kamil Musilek, et al.
Talanta|May 24, 2024
Towards cost-effective drug discovery: Reusable immobilized enzymes for neurological disease researchRudolf Andrys, Charline Monnier, Evica Antonijević Miljaković, et al.
Journal of Medicinal Chemistry|October 11, 2007
Design of a potent reactivator of tabun-inhibited acetylcholinesterase--synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203)Kamil Musilek, Daniel Jun, Jiri Cabal, et al.
Basic & Clinical Pharmacology & Toxicology|April 18, 2014
In vivo evaluation of cholinesterase activity, oxidative stress markers, cyto- and genotoxicity of K048 oxime–a promising antidote against organophosphate poisoningSuzana Zunec, Nevenka Kopjar, Davor Zeljezić, et al.
Molecules (Basel, Switzerland)|October 26, 2007
Targeted synthesis of 1-(4-hydroxyiminomethylpyridinium)-3-pyridiniumpropane dibromide--a new nerve agent reactivatorKamil Kuca, Kamil Musilek, Martin Paar, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 18, 2010
A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and miceJiri Kassa, Jana Zdarova Karasova, Filip Caisberger, et al.
ACS Omega|March 18, 2024
C-3 Steroidal Hemiesters as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 10Michaela Hanzlova, Barbora Slavikova, Marina Morozovova, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 24, 2010
Changes of rat plasma total low molecular weight antioxidant level after tabun exposure and consequent treatment by acetylcholinesterase reactivatorsMiroslav Pohanka, Jana Zdarova Karasova, Kamil Musilek, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 12, 2012
Structure-activity relationship for the reactivators of acetylcholinesterase inhibited by nerve agent VXKamil Kuca, Kamil Musilek, Daniel Jun, et al.
Pageof 20